Criminal Fraud Cases

Related Enforcement Actions

This case was filed on December 13, 2023 in the Southern District of Florida.

This case was resolved on March 28, 2024.

Related Document(s):

Information

Plea Agreement

Press Release

A Georgia businessman, a former Honduran government official, and a former Florida resident were indicted for their alleged participation in an international scheme to pay and conceal bribes to Honduran government officials to secure contracts to provide uniforms and other goods to the Honduran National Police in violation of the Foreign Corrupt Practices Act and money laundering laws.

The indictment was returned on November 28, 2023, and was unsealed on December 20, 2023 in the Southern District of Florida. 

Pursuant to the Criminal Division’s Voluntary Self-Disclosure and Corporate Enforcement Policy, on November 16, 2023, the Fraud Section and the U.S. Attorney’s Office for the Northern District of California declined to prosecute Lifecore Biomedical, Inc. (formerly known as Landec Corporation) for violations of the Foreign Corrupt Practices Act (FCPA) because the company voluntarily self-disclosed the misconduct, fully cooperated with the government’s investigation, and timely and appropriately remediated.

As part of the agreement, the company agreed to disgorge the costs it avoided having to pay as a result of the bribery scheme.

From approximately May 2018 to August 2019, certain officers, employees, and agents of Yucatan Foods L.P., Lifecore’s former U.S. subsidiary, paid bribes to one or more Mexican government officials, both prior to and after Lifecore’s acquisition of Yucatan.

Pursuant to the Criminal Division’s Voluntary Self-Disclosure and Corporate Enforcement Policy, on October 25, 2023, the Fraud Section declined to prosecute HealthSun Health Plans, Inc. for violations of United States Code Title 18 Sections 1343, 1347, and 1349, because the company voluntarily self-disclosed the misconduct, cooperated with the government’s investigation, and timely and appropriately remediated.

As part of the agreement the company agreed to repay approximately $53 million in overpayments made by the U.S. Centers for Medicare and Medicaid Services (“CMS”).

From approximately 2015 until early 2020, HealthSun’s former Director of Medicare Riks Adjustment Analytics orchestrated a scheme to submit false and fraudulent information to CMS in order to increase the amount HealthSun received for certain of its Medicare Advantage enrollees.